Jon Congleton
2015 - Nivalis Therapeutics
In 2015, Jon Congleton earned a total compensation of $3.4M as Chief Executive Officer and President at Nivalis Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $206,250 |
|---|---|
| Option Awards | $2,792,832 |
| Salary | $375,000 |
| Other | $42,750 |
| Total | $3,416,832 |
Congleton received $2.8M in option awards, accounting for 82% of the total pay in 2015.
Congleton also received $206.3K in non-equity incentive plan, $375K in salary and $42.8K in other compensation.
Rankings
In 2015, Jon Congleton's compensation ranked 2,678th out of 13,638 executives tracked by ExecPay. In other words, Congleton earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,678 out of 13,638 | 80th |
Division Manufacturing | 947 out of 5,190 | 82nd |
Major group Chemicals And Allied Products | 347 out of 1,854 | 81st |
Industry group Drugs | 272 out of 1,528 | 82nd |
Industry Pharmaceutical Preparations | 214 out of 1,182 | 82nd |
Source: SEC filing on March 21, 2016.
Congleton's colleagues
We found two more compensation records of executives who worked with Jon Congleton at Nivalis Therapeutics in 2015.